These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 30356740)
1. Protective Effect of Xu Q; Gu S; Chen Y; Quan J; Lv L; Chen D; Zheng B; Xu L; Li L Front Microbiol; 2018; 9():2396. PubMed ID: 30356740 [No Abstract] [Full Text] [Related]
2. Impact of encapsulating a probiotic (Pediococcus pentosaceus Li05) within gastro-responsive microgels on Clostridium difficile infections. Xie J; Yao M; Lu Y; Yu M; Han S; McClements DJ; Xiao H; Li L Food Funct; 2021 Apr; 12(7):3180-3190. PubMed ID: 33734244 [TBL] [Abstract][Full Text] [Related]
3. Pediococcus pentosaceus LI05 alleviates DSS-induced colitis by modulating immunological profiles, the gut microbiota and short-chain fatty acid levels in a mouse model. Bian X; Yang L; Wu W; Lv L; Jiang X; Wang Q; Wu J; Li Y; Ye J; Fang D; Shi D; Wang K; Wang Q; Lu Y; Xie J; Xia J; Li L Microb Biotechnol; 2020 Jul; 13(4):1228-1244. PubMed ID: 32363766 [TBL] [Abstract][Full Text] [Related]
4. New strain of Jiang XW; Li YT; Ye JZ; Lv LX; Yang LY; Bian XY; Wu WR; Wu JJ; Shi D; Wang Q; Fang DQ; Wang KC; Wang QQ; Lu YM; Xie JJ; Li LJ World J Gastroenterol; 2020 Oct; 26(40):6224-6240. PubMed ID: 33177795 [TBL] [Abstract][Full Text] [Related]
5. Effects of Pediococcus pentosaceus LI05 on immunity and metabolism in germ-free rats. Jiang S; Xia J; Lv L; Wang Q; Li Y; Xu Q; Bian X; Ye J; Yang L; Jiang H; Yan R; Wang K; Fang D; Li L Food Funct; 2021 Jun; 12(11):5077-5086. PubMed ID: 33960989 [TBL] [Abstract][Full Text] [Related]
6. Probiotic Han S; Wang K; Shen J; Xia H; Lu Y; Zhuge A; Li S; Qiu B; Zhang S; Dong X; Yao M; Li L Nutrients; 2023 Nov; 15(23):. PubMed ID: 38068723 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of Wu Y; Li S; Lv L; Jiang S; Xu L; Chen H; Li L Food Funct; 2024 Apr; 15(7):3692-3708. PubMed ID: 38488110 [No Abstract] [Full Text] [Related]
8. Whole-genome sequence assembly of Pediococcus pentosaceus LI05 (CGMCC 7049) from the human gastrointestinal tract and comparative analysis with representative sequences from three food-borne strains. Lv LX; Li YD; Hu XJ; Shi HY; Li LJ Gut Pathog; 2014; 6():36. PubMed ID: 25349631 [TBL] [Abstract][Full Text] [Related]
9. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 prevents CCl Shi D; Lv L; Fang D; Wu W; Hu C; Xu L; Chen Y; Guo J; Hu X; Li A; Guo F; Ye J; Li Y; Andayani D; Li L Sci Rep; 2017 Jul; 7(1):6927. PubMed ID: 28761060 [TBL] [Abstract][Full Text] [Related]
10. Administration of Lactobacillus salivarius LI01 or Pediococcus pentosaceus LI05 improves acute liver injury induced by D-galactosamine in rats. Lv LX; Hu XJ; Qian GR; Zhang H; Lu HF; Zheng BW; Jiang L; Li LJ Appl Microbiol Biotechnol; 2014 Jun; 98(12):5619-32. PubMed ID: 24639205 [TBL] [Abstract][Full Text] [Related]
11. Deng H; Yang S; Zhang Y; Qian K; Zhang Z; Liu Y; Wang Y; Bai Y; Fan H; Zhao X; Zhi F Front Microbiol; 2018; 9():2976. PubMed ID: 30619112 [No Abstract] [Full Text] [Related]
12. Wu Z; Xu Q; Gu S; Chen Y; Lv L; Zheng B; Wang Q; Wang K; Wang S; Xia J; Yang L; Bian X; Jiang X; Zheng L; Li L Front Microbiol; 2022; 13():841920. PubMed ID: 35663882 [No Abstract] [Full Text] [Related]
13. Establishment of an Endogenous Oka K; Osaki T; Hanawa T; Kurata S; Sugiyama E; Takahashi M; Tanaka M; Taguchi H; Kamiya S Front Microbiol; 2018; 9():1264. PubMed ID: 29967595 [No Abstract] [Full Text] [Related]
14. Domestic canines do not display evidence of gut microbial dysbiosis in the presence of Clostridioides (Clostridium) difficile, despite cellular susceptibility to its toxins. Stone NE; Nunnally AE; Jimenez V; Cope EK; Sahl JW; Sheridan K; Hornstra HM; Vinocur J; Settles EW; Headley KC; Williamson CHD; Rideout JR; Bolyen E; Caporaso JG; Terriquez J; Monroy FP; Busch JD; Keim P; Wagner DM Anaerobe; 2019 Aug; 58():53-72. PubMed ID: 30946985 [TBL] [Abstract][Full Text] [Related]
15. Berberine blocks the relapse of Clostridium difficile infection in C57BL/6 mice after standard vancomycin treatment. Lv Z; Peng G; Liu W; Xu H; Su J Antimicrob Agents Chemother; 2015 Jul; 59(7):3726-35. PubMed ID: 25824219 [TBL] [Abstract][Full Text] [Related]
16. Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection. Vincent C; Miller MA; Edens TJ; Mehrotra S; Dewar K; Manges AR Microbiome; 2016 Mar; 4():12. PubMed ID: 26975510 [TBL] [Abstract][Full Text] [Related]
17. Faecalibacterium prausnitzii and a Prebiotic Protect Intestinal Health in a Mouse Model of Antibiotic and Clostridium difficile Exposure. Roychowdhury S; Cadnum J; Glueck B; Obrenovich M; Donskey C; Cresci GAM JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1156-1167. PubMed ID: 29385239 [TBL] [Abstract][Full Text] [Related]
18. Modified Mouse Model of Clostridioides difficile Infection as a Platform for Probiotic Efficacy Studies. De Wolfe TJ; Kates AE; Barko L; Darien BJ; Safdar N Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 30988143 [TBL] [Abstract][Full Text] [Related]
19. Pediococcus pentosaceus PP34 Ameliorates 5-Fluorouracil-Induced Intestinal Mucositis via Inhibiting Oxidative Stress and Restoring the Gut Microbiota. He Y; Li F; Zhang Y; Zhu X; Lin Z; Li L; Nawaz S; Kulyar MF; Iqbal M; Li J Probiotics Antimicrob Proteins; 2024 Jul; ():. PubMed ID: 39046671 [TBL] [Abstract][Full Text] [Related]
20. Active and Secretory IgA-Coated Bacterial Fractions Elucidate Dysbiosis in Clostridium difficile Infection. Džunková M; Moya A; Vázquez-Castellanos JF; Artacho A; Chen X; Kelly C; D'Auria G mSphere; 2016; 1(3):. PubMed ID: 27303742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]